December 21, 2021
Q4 2021
Summary and Key Findings:
  • 65 samples were reported between September & December 2021
  • Most “heroin” samples contained fentanyl cut with xylazine
  • Cocaine and methamphetamine samples were not adulterated; fentanyl contamination was not observed in this sample set*
  • para-Fluorofentanyl was identified as the primary opioid in some “heroin” samples, once as the only opioid (without fentanyl or heroin)
  • Two “heroin” samples were found to contain fentanyl & stimulants
  • Counterfeit “Xanax” found to contain an NPS benzodiazepine